NGMD NuGen Medical Devices Inc.

0.0105USD0.0150 CAD · TSXV0.00%Mkt Cap: 2.38M USDP/E: —

NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection de…

Key Statistics

Company
Market Cap2.38M USD
Enterprise Value14.91M USD
Revenue (TTM)103.96K USD
Gross Profit92.52K USD
Net Income (TTM)-5.47M USD
Revenue/Share0.0007 USD
Last Price0.0105 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA67054F1009
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.27
EV/Revenue143.40
P/S22.90
P/B-0.20
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.01050% of range0.0315
52W High0.0315 USD
52W Low0.0105 USD
Profitability
Gross Margin51.31%
Oper. Margin-2992.62%
EBITDA Margin0.00%
Profit Margin-3034.00%
ROE56.98%
ROA-182.35%
ROIC-834.96%
ROCE-637.35%
Growth
Revenue Growth-76.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.49M USD
CapEx (TTM)211.33K USD
FCF Margin-3313.23%
FCF Yield-144.69%
Net Debt12.53M USD
Net Debt/EBITDA-4.43
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.27
Current Ratio0.39
Quick Ratio0.22
Book Value/Sh-0.05 USD
Cash/Share0.0021 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.227.04M
Float221.60M
Insiders2.39%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short5.35K
Short (prev mo.)5.35K
Technical
SMA 500.0105 (-0.0%)
SMA 2000.0139 (-24.8%)
Beta1.53
S&P 52W Chg12.00%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)42.6
MACD-0.0000
MACD Signal-0.0000
MACD Hist.+0.0000
BB Upper0.0105 USD
BB Middle0.0105 USD
BB Lower0.0105 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)—

About NuGen Medical Devices (CVE: NGMD)

›

NuGen Medical Devices (CVE: NGMD) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.

The shares were at 0.0150 CAD on 18 November 2026, down 62.5% over 52 weeks. Its 52-week range is 0.0150 CAD to 0.0450 CAD, and it trades at the bottom of that range.

Its market capitalisation is 3.41M CAD.

NuGen Medical Devices reports return on equity of 57.0% and revenue down 76.9% year over year.

Its debt exceeds its cash by 17.92M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 1 December 2026.